Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Main Authors: | Maya Rosana Amalia, Susi Herminingsih |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2021-12-01
|
Series: | European Cardiology Review |
Online Access: | https://www.ecrjournal.com/articleindex/ecr.2021.16.PO5 |
Similar Items
-
Young coronary artery disease in patients undergoing percutaneous coronary intervention
by: Zuhdi, A.S., et al.
Published: (2013) -
Young coronary artery disease in patients undergoing percutaneous coronary intervention
by: AS Zuhdi, et al.
Published: (2013-11-01) -
INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015-09-01) -
INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015-09-01) -
Prevalence of CYP2C19 gene polymorphism in patients with acute coronary syndrome undergoing PCI
by: S. Ramesh, et al.
Published: (2014-11-01)